Skip to main content
Clinical Trials/NCT02619487
NCT02619487
Withdrawn
Not Applicable

The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes

University of Louisville1 site in 1 countryMarch 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 1
Sponsor
University of Louisville
Locations
1
Primary Endpoint
glycemic control assessed by HbA1C level.
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to determine whether a simple text message reminder sent to the parent of an child/adolescent with Type 1 Diabetes(or parent and adolescent) is effective in helping the individual(or parent) become more compliant with self-managing the Type 1 Diabetes (T1D). There will be 5 arms: text message sent to parents of children age 8-12 years old with T1D, text messages sent to parents of adolescents ,age 13-18 years old, with T1D,text messages sent to parents of adolescents with T1D as well as the adolescent with T1D,no text message sent to parents of children age 8-12 years, and no text message sent to adolescents or parents of adolescents age 13-18 years old.

Detailed Description

Managing Type 1 Diabetes requires daily checks of blood glucose and medication adjustments. Children and adolescents are known to have more difficulty with this than adults. Parents/legal guardians also face the task of helping with this self-management. A weekly text message regarding Type 1 Diabetes, sent to the parent or the parent and adolescent, may help to remind and motivate an individual to perform the daily tasks needed to manage their Type 1 Diabetes.

Registry
clinicaltrials.gov
Start Date
March 2019
End Date
December 13, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gwendolyn Pierce

Research Nurse

University of Louisville

Eligibility Criteria

Inclusion Criteria

  • Be willing to agree to participate(assent) in the study and have the permission of the parent to do so.
  • Have a diagnosis of Type 1 diabetes for ≥ one year.
  • Be aged 8 to 18 years old.
  • Be on insulin therapy for ≥ one year.
  • Have a parent/legal guardian with access to a working cell phone or have a parent/legal guardian with access to a working cell phone and have a working cell phone (if 13 years of age or older).
  • Utilize one of the following mobile carriers: T-Mobile, Sprint, Verizon, AT\&T, or Virgin Mobile.
  • The parent/legal guardian must express intent to maintain a carrier plan for the duration of the study.
  • The parent/legal guardian must be able to read English OR the parent/legal guardian and the adolescent must be able to read English.

Exclusion Criteria

  • Participants, who in the opinion of the investigator, have any contraindication to tight glycemic control.
  • Individuals who are unable to undertake blood glucose testing during the study period
  • Individuals who are deemed unable or unlikely to comply with the protocol.

Outcomes

Primary Outcomes

glycemic control assessed by HbA1C level.

Time Frame: up to one year after randomization occurs

review of lab value

Secondary Outcomes

  • number of hospitalizations related to T1D(up to one year after randomization occurs)
  • number of episodes of severe hypoglycemia(up to one year after randomization occurs)
  • number of episodes of Diabetic Ketoacidosis (DKA)(up to one year after randomization occurs)
  • number of patient contacts to the diabetes educator(up to one year after randomization occurs)

Study Sites (1)

Loading locations...

Similar Trials